Angeline Pei Chiew Lim

Title: Angeline Pei Chiew Lim: Innovator in Dengue Virus Research

Introduction

Angeline Pei Chiew Lim is a notable inventor based in Singapore, recognized for her contributions to medical research, particularly in the field of dengue virus treatment. With a total of two patents to her name, she has made significant strides in developing therapeutic solutions for dengue virus infections.

Latest Patents

Her latest patents focus on human monoclonal antibodies with specificity for the dengue virus serotype 1 E protein. These patents detail compositions and methods for the treatment or prevention of dengue virus infection in vertebrate subjects. Specifically, they disclose human neutralizing monoclonal antibodies isolated from EBV immortalized B cells derived from patients who have recovered from dengue infection. The methods outlined in these patents provide a framework for administering such antibodies in amounts effective to reduce, eliminate, or prevent relapse from infection.

Career Highlights

Angeline has worked with prestigious institutions such as the National University of Singapore and DSO National Laboratories. Her work in these organizations has contributed to advancing research in infectious diseases and developing innovative treatment methods.

Collaborations

Some of her notable coworkers include Paul Macary and Ee Ping Evelyn Teoh, who have collaborated with her on various research projects.

Conclusion

Angeline Pei Chiew Lim's innovative work in the field of dengue virus research highlights her commitment to improving public health through scientific advancements. Her patents represent a significant contribution to the ongoing battle against infectious diseases.